JDD Buzz Series | Metformin’s Potential Chemopreventive Effect
A commonly used diabetes medication may help prevent non-melanoma skin cancer. A study in the December Journal of Drugs in Dermatology analyzed whether metformin exposure is associated with a reduced risk of non-melanoma skin cancer. The study also stratified findings by race/ethnicity, which makes it unique among similar research studies.
I interviewed author Tiffany Jow Libby, MD, FAAD, FACMS …
Continue reading "JDD Buzz Series | Metformin’s Potential Chemopreventive Effect"